Juniper names Jeffrey Young as CFO
Mr. Young brings over 20 years of financial leadership in the life sciences sector to Juniper. He most recently served as Chief Financial Officer and Treasurer of OvaScience, a global fertility company focused on new treatment options for women.
During his two-year tenure at OvaScience, Mr. Young led the company's fundraising efforts and international tax strategy.
He was previously the Chief Financial Officer and Treasurer of Transmedics, a developer of medical devices for the maintenance and transport of organs between donors and recipients.
Before that, Mr. Young served as Chief Financial Officer and Treasurer at Lantheus Medical Imaging, where he led and managed multiple debt offerings.
He joined Lantheus from Critical Therapeutics, where he was Chief Accounting Officer.
Early in his career, he worked in various finance roles at PerkinElmer, Inc., and PriceWaterhouseCoopers LLP.
Mr. Young is a Certified Public Accountant and holds a B.S. in Business Administration from Georgetown University.
He will succeed George O. Elston, the Company's outgoing Chief Financial Officer, Treasurer and Secretary, who will be stepping down at the end of the year. ■
What to read next